- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 20, 2026 | 1.68M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 1.68M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 946.86K sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 57.81K sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 27.15K sh |
| Capex | Q3 2026 · Mar 31, 2026 | $1.04M |
| Capex | Q3 2026 · Mar 31, 2025 | $4.55K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$5.19M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$5.82M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $15.62M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $17.96M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $11.97M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $10.74M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $29.11M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $18.4M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $6.28M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $3.38M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $4.81M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $3.67M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $5.97M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $4.13M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $17.16M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $5.52M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $21.59M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $14.87M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$1.39 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$7.99 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | $21.79 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | $2.83 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$1.39 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$7.99 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | $21.79 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | $2.83 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $3.81M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $8.44M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $446.38K |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $2.01M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $78.89K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $881.54K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $5.34K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $85.69K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$2.32M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$7.56M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$3.11M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$2.13M |
| Net Income | Q3 2026 · Mar 31, 2025 | $1.26M |
| Net Income | Q3 2026 · Mar 31, 2025 | $76.93K |
| Net Income | Q3 2026 · Dec 31, 2024 | −$232.33K |
| Net Income | Q3 2026 · Sep 30, 2024 | −$950.71K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$4.19M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$13.6M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$43.41K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.55M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $6.42K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $8.61K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $486.28K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $882.41K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.49M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $2.76M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $180.24K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $293.38K |
| Short Term Debt | Q3 2026 · Feb 28, 2025 | $61.73K |